Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma
about
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.DPPIV/CD26: a tumor suppressor or a marker of malignancy?International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@ast
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@en
Regulation of somatostatin rec ...... alignant pleural mesothelioma.
@nl
type
label
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@ast
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@en
Regulation of somatostatin rec ...... alignant pleural mesothelioma.
@nl
prefLabel
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@ast
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@en
Regulation of somatostatin rec ...... alignant pleural mesothelioma.
@nl
P2093
P2860
P356
P1476
Regulation of somatostatin rec ...... malignant pleural mesothelioma
@en
P2093
C Morimoto
H Yamazaki
J Yamamoto
T Kishimoto
P2860
P2888
P304
P356
10.1038/BJC.2014.151
P407
P577
2014-04-17T00:00:00Z
P5875
P6179
1021211782